IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Catabasis Pharmaceuticals in

CUSIP: 14875P107 | 96 institutional holders

Quarters

Q4 2018Q3 2018Q2 2018Q1 2018Q4 2017
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2018

SV Life Sciences Advisers, LLC285,765
0.8% of portfolio›$1.2K
StyleTurnoverLocationFiled
SV Life Sciences Advisers, LLC
285,765$1.2K0.8%N/AN/ABoston, MA2019-02-14